Literature DB >> 7518163

Human papillomavirus type 1 E4 protein is a zinc-binding protein.

S Roberts1, I Ashmole, T M Sheehan, A H Davies, P H Gallimore.   

Abstract

Study of the human papillomavirus (HPV) E4 gene product has focused largely on HPV type 1 (HPV 1) primarily because of the large quantities of protein that can be purified from HPV 1-induced warts. We have extended the characterization of the HPV 1 E4 protein and, in this study, have shown that protein purified from clinical material and a heterologous expression system contains the divalent metal ion zinc. Furthermore, using a [65Zn]Cl2 dot-blot assay, we have shown that this binding is specific for zinc and those divalent cations that are known to structurally substitute zinc in metalloproteins. Mutational analysis has demonstrated that histidine amino acids (residues 56, 86, and 121), but not the cysteine residue (115), are essential for the zinc-binding activity of the E4 protein. Two assayable functions of E4 are dimerization and the formation of E4/cytokeratin structures in cultured cells; however, neither activity is abrogated by the loss of zinc binding.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518163     DOI: 10.1006/viro.1994.1408

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Role of calpain in the formation of human papillomavirus type 16 E1^E4 amyloid fibers and reorganization of the keratin network.

Authors:  Jameela Khan; Clare E Davy; Pauline B McIntosh; Deborah J Jackson; Steven Hinz; Qian Wang; John Doorbar
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

2.  Mutational analysis of human papillomavirus E4 proteins: identification of structural features important in the formation of cytoplasmic E4/cytokeratin networks in epithelial cells.

Authors:  S Roberts; I Ashmole; L J Gibson; S M Rookes; G J Barton; P H Gallimore
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

3.  The ND10 component promyelocytic leukemia protein relocates to human papillomavirus type 1 E4 intranuclear inclusion bodies in cultured keratinocytes and in warts.

Authors:  Sally Roberts; Michele L Hillman; Gillian L Knight; Phillip H Gallimore
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  Mutational analysis of the human papillomavirus type 16 E1--E4 protein shows that the C terminus is dispensable for keratin cytoskeleton association but is involved in inducing disruption of the keratin filaments.

Authors:  S Roberts; I Ashmole; S M Rookes; P H Gallimore
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

5.  Cooperation between different forms of the human papillomavirus type 1 E4 protein to block cell cycle progression and cellular DNA synthesis.

Authors:  Gillian L Knight; John R Grainger; Phillip H Gallimore; Sally Roberts
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 6.  The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.

Authors:  Maciej Lazarczyk; Patricia Cassonnet; Christian Pons; Yves Jacob; Michel Favre
Journal:  Microbiol Mol Biol Rev       Date:  2009-06       Impact factor: 11.056

7.  Identification of an arginine-rich motif in human papillomavirus type 1 E1;E4 protein necessary for E4-mediated inhibition of cellular DNA synthesis in vitro and in cells.

Authors:  Sally Roberts; Sarah R Kingsbury; Kai Stoeber; Gillian L Knight; Phillip H Gallimore; Gareth H Williams
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.